Calcium influx pathways in breast cancer: Opportunities for pharmacological intervention

British Journal of Pharmacology

Volumn 171, Issue 4, 2014, Pages 945-960

  Azimi, I ^a   Roberts Thomson, S J ^a   Monteith, G R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

breast cancer; calcium channels; calcium influx; calcium signalling; oncology

Indexed keywords

1 (2 BROMOPHENYL) 3 [1 (5 TRIFLUOROMETHYL 2 PYRIDINYL) 3 PYRROLIDINYL]UREA; 1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 1 PHENYLETHYL 4 (BENZYLOXY) 3 METHOXYBENZYL(2 AMINOETHYL)CARBAMATE; 2 AMINOETHOXYDIPHENYLBORANE; 3 [7 TRIFLUOROMETHYL 5 (2 TRIFLUOROMETHYL PHENYL) 1H BENZIMID AZOL 2 YL] 1 OXA 2 AZA SPIRO[4.5]DEC 2 ENEHYDROCHLORIDE; 3 [[5 (2,3 DICHLOROPHENYL) 1H TETRAZOL 1 YL]METHYL]PYRIDINE; 4ALPHA PHORBOL DIDECANOATE; A 740003; AMIDE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CAPSAICIN; CARBAMIC ACID DERIVATIVE; GSK 1016790 A; GSK 2193874; IMIDAZOLE DERIVATIVE; JNJ 41876666; LIGAND GATED CALCIUM CHANNEL; LIGAND GATED ION CHANNEL; MIBEFRADIL; N (3 AMINOPROPYL) 2 [[(3 METHYLPHENYL)METHYL]OXY] N (2 THIENYLMETHYL)BENZAMIDE HYDROCHLORIDE SALT; N (4 METHOXYPHENYL) 4 MENTHONE 3 CARBOXAMIDE; N [1 [[4 [2 [[(2,4 DICHLOROPHENYL)SULFONYL]AMINO] 3 HYDROXYPROPANOYL] 1 PIPERAZINYL]CARBONYL] 3 METHYLBUTYL] 1 BENZOTHIOPHENE 2 CARBOXAMIDE; NNC 55 0396; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; RQ 00203078; SB 209712; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; WAIXENICIN; WS 12;

BREAST CANCER; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CANCER CELL; CANCER GROWTH; CANCER PROGNOSIS; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CHANNEL GATING; HUMAN; LACTATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

BREAST CANCER; CALCIUM CHANNELS; CALCIUM INFLUX; CALCIUM SIGNALLING; ONCOLOGY;

ANIMALS; BREAST NEOPLASMS; CALCIUM; CALCIUM CHANNELS; CALCIUM SIGNALING; FEMALE; HUMANS; LACTATION;

EID: 84893142524     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12486     Document Type: Review

References (165)

1. Afrasiabi E, Hietamaki M, Viitanen T, Sukumaran P, Bergelin N, Tornquist K, (2010). Expression and significance of HERG (KCNH2) potassium channels in the regulation of MDA-MB-435S melanoma cell proliferation and migration. Cell Signal 22: 57-64.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Catterall WA, Spedding M, Peters JA, Harmar AJ, and, CGTP Collaborators, (2013). The Concise Guide to PHARMACOLOGY 2013/14: Overview. Br J Pharmacol 170: 1449-1867.
3. Amantini C, Mosca M, Nabissi M, Lucciarini R, Caprodossi S, Arcella A, et al. (2007). Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation. J Neurochem 102: 977-990.
4. Amantini C, Ballarini P, Caprodossi S, Nabissi M, Morelli MB, Lucciarini R, et al. (2009). Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner. Carcinogenesis 30: 1320-1329.
5. 2+ antagonist (nifedipine) in hypertensive patients. Jpn Heart J 17: 479-484.
6. Aydar E, Yeo S, Djamgoz M, Palmer C, (2009). Abnormal expression, localization and interaction of canonical transient receptor potential ion channels in human breast cancer cell lines and tissues: a potential target for breast cancer diagnosis and therapy. Cancer Cell Int 9: 23.
7. Barley NF, Howard A, O'Callaghan D, Legon S, Walters JRF, (2001). Epithelial calcium transporter expression in human duodenum. Am J Physiol Gastrointest Liver Physiol 280: G285-G290.
8. 2+ increase associated with the ATP-induced increase in ciliary beat frequency. Am J Physiol Cell Physiol 287: C1114-C1124.
9. Baselga J, Norton L, Albanell J, Kim YM, Mendelsohn J, (1999). Recombinant humanized anti-HER2 antibody (Herceptin (TM)) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts (vol 58, pg 2825, 1998). Cancer Res 59: 2020-2020.
10. Basora N, Boulay G, Bilodeau L, Rousseau E, Payet MD, (2003). 20-hydroxyeicosatetraenoic acid (20-HETE) activates mouse TRPC6 channels expressed in HEK293 cells. J Biol Chem 278: 31709-31716.
11. 2+ inhibited channel and kinase. Adv Exp Med Biol 704: 173-183.
12. Belpomme D, Gauthier S, Pujade-Lauraine E, Facchini T, Goudier MJ, Krakowski I, et al. (2000). Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma. Ann Oncol 11: 1471-1476.
13. Benham CD, Gunthorpe MJ, Davis JB, (2003). TRPV channels as temperature sensors. Cell Calcium 33: 479-487.
14. Berridge MJ, Bootman MD, Roderick HL, (2003). Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4: 517-529.
15. 2+ channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms. Mol Pharmacol 62: 210-219.
16. Bidaud I, Mezghrani A, Swayne LA, Monteil A, Lory P, (2006). Voltage-gated calcium channels in genetic diseases. Biochim Biophys Acta 1763: 1169-1174.
17. Bidaux G, Flourakis M, Thebault S, Zholos A, Beck B, Gkika D, et al. (2007). Prostate cell differentiation status determines transient receptor potential melastatin member 8 channel subcellular localization and function. J Clin Invest 117: 1647-1657.
18. Bohlen CJ, Priel A, Zhou S, King D, Siemens J, Julius D, (2010). A bivalent tarantula toxin activates the capsaicin receptor, TRPV1, by targeting the outer pore domain. Cell 141: 834-845.
19. Bolanz KA, Hediger MA, Landowski CP, (2008). The role of TRPV6 in breast carcinogenesis. Mol Cancer Ther 7: 271-279.
20. Bortolotto ZA, Bashir ZI, Davies CH, Collingridge GL, (1994). A molecular switch activated by metabotropic glutamate receptors regulates induction of long-term potentiation. Nature 368: 740-743.
21. 2+ levels. Cell 131: 1327-1339.
22. Cain SM, Snutch TP, (2011). Voltage-gated calcium channels and disease. Biofactors 37: 197-205.
23. Carafoli E, (1987). Intracellular calcium homeostasis. Annu Rev Biochem 56: 395-433.
24. Carafoli E, Santella L, Branca D, Brini M, (2001). Generation, control, and processing of cellular calcium signals. Crit Rev Biochem Mol Biol 36: 107-260.
25. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D, (1997). The capsaicin receptor: a heat-Activated ion channel in the pain pathway. Nature 389: 816-824.
26. Catterall WA, (2011). Voltage-gated calcium channels. Cold Spring Harb Perspect Biol 3: a003947.
27. Chambers AF, (2009). MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res 69: 5292-5293.
28. 2+ sparks. Cell Calcium 20: 129-140.
29. Chodon D, Guilbert A, Dhennin-Duthille I, Gautier M, Telliez MS, Sevestre H, et al. (2010). Estrogen regulation of TRPM8 expression in breast cancer cells. BMC Cancer 10: 212.
30. 2+ current, IL-2 production and activation in T lymphocytes. Br J Pharmacol 113: 861-868.
31. Clapham DE, (2002). Signal transduction. Hot and cold TRP ion channels. Science 295: 2228-2229.
32. Clapham DE, (2007). Calcium signaling. Cell 131: 1047-1058.
33. 2+, calcineurin, and NF-AT. Cell 96: 611-614.
34. 2+ signaling as a consequence of EGF-induced epithelial-mesenchymal transition in breast cancer cells. PLoS ONE 6: e23464.
35. 2+ influx in MDA-MB-468 breast cancer cells and the effect of EGF-induced EMT on calcium entry. PLoS ONE 7: e36923.
36. Davis FM, Azimi I, Faville RA, Peters AA, Jalink K, Putney JW Jr, et al. (2013). Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent. Oncogene (in press).
37. Dellis O, Rossi AM, Dedos SG, Taylor CW, (2008). Counting functional inositol 1,4,5-trisphosphate receptors into the plasma membrane. J Biol Chem 283: 751-755.
38. Dhennin-Duthille I, Gautier M, Faouzi M, Guilbert A, Brevet M, Vaudry D, et al. (2011). High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters. Cell Physiol Biochem 28: 813-822.
39. Dona M, Dell'Aica I, Pezzato E, Sartor L, Calabrese F, Della Barbera M, et al. (2004). Hyperforin inhibits cancer invasion and metastasis. Cancer Res 64: 6225-6232.
40. Donnelly-Roberts DL, Namovic MT, Surber B, Vaidyanathan SX, Perez-Medrano A, Wang Y, et al. (2009). [H-3]A-804598 ([H-3]2-cyano-1-[(1S)-1-phenylethyl]-3- quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors. Neuropharmacology 56: 223-229.
41. El Hiani Y, Ahidouch A, Roudbaraki M, Guenin S, Brule G, Ouadid-Ahidouch H, (2006). Calcium-sensing receptor stimulation induces nonselective cation channel activation in breast cancer cells. J Membr Biol 211: 127-137.
42. El Hiani Y, Ahidouch A, Lehen'kyi V, Hague F, Gouilleux F, Mentaverri R, et al. (2009). Extracellular signal-regulated kinases 1 and 2 and TRPC1 channels are required for calcium-sensing receptor-stimulated MCF-7 breast cancer cell proliferation. Cell Physiol Biochem 23: 335-346.
43. Ertel EA, Campbell KP, Harpold MM, Hofmann F, Mori Y, Perez-Reyes E, et al. (2000). Nomenclature of voltage-gated calcium channels. Neuron 25: 533-535.
44. Faddy HM, Smart CE, Xu R, Lee GY, Kenny PA, Feng M, et al. (2008). Localization of plasma membrane and secretory calcium pumps in the mammary gland. Biochem Biophys Res Commun 369: 977-981.
45. 2+ clearance distinguish Th1 and Th2 lymphocytes. J Immunol 164: 1153-1160.
46. Faouzi M, Hague F, Potier M, Ahidouch A, Sevestre H, Ouadid-Ahidouch H, (2011). Down-regulation of Orai3 arrests cell-cycle progression and induces apoptosis in breast cancer cells but not in normal breast epithelial cells. J Cell Physiol 226: 542-551.
47. Faouzi M, Kischel P, Hague F, Ahidouch A, Benzerdjeb N, Sevestre H, et al. (2013). ORAI3 silencing alters cell proliferation and cell cycle progression via c-myc pathway in breast cancer cells. Biochim Biophys Acta 1833: 752-760.
48. Farrell AW, Gadeock S, Pupovac A, Wang B, Jalilian I, Ranson M, et al. (2010). P2X7 receptor activation induces cell death and CD23 shedding in human RPMI 8226 multiple myeloma cells. Biochim Biophys Acta 1800: 1173-1182.
49. Feng M, Grice DM, Faddy HM, Nguyen N, Leitch S, Wang Y, et al. (2010). Store-independent activation of Orai1 by SPCA2 in mammary tumors. Cell 143: 84-98.
50. Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, et al. (2006). A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441: 179-185.
51. 2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression. Oncogene 22: 7858-7861.
52. Frandsen SK, Gissel H, Hojman P, Tramm T, Eriksen J, Gehl J, (2012). Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res 72: 1336-1341.
53. Gehring MP, Pereira TCB, Zanin RF, Borges MC, Braga A, Battastini AMO, et al. (2012). P2X7 receptor activation leads to increased cell death in a radiosensitive human glioma cell line. Purinergic Signal 8: 729-739.
54. Gomtsyan A, Bayburt EK, Schmidt RG, Surowy CS, Honore P, Marsh KC, et al. (2008). Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H- indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management. J Med Chem 51: 392-395.
55. van de Graaf SFJ, Hoenderop JGJ, Bindels RJM, (2006). Regulation of TRPV5 and TRPV6 by associated proteins. Am J Physiol Renal Physiol 290: F1295-F1302.
56. Grice DM, Vetter I, Faddy HM, Kenny PA, Roberts-Thomson SJ, Monteith GR, (2010). Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of insulin-like growth factor receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231. J Biol Chem 285: 37458-37466.
57. Guilbert A, Dhennin-Duthille I, Hiani YEL, Haren N, Khorsi H, Sevestre H, et al. (2008). Expression of TRPC6 channels in human epithelial breast cancer cells. BMC Cancer 8: 125.
58. Guilbert A, Gautier M, Dhennin-Duthille I, Haren N, Sevestre H, Ouadid-Ahidouch H, (2009). Evidence that TRPM7 is required for breast cancer cell proliferation. Am J Physiol Cell Physiol 297: C493-C502.
59. + channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry. J Cell Physiol 227: 3837-3846.
60. Hanahan D, Weinberg RA, (2011). Hallmarks of cancer: the next generation. Cell 144: 646-674.
61. 2+ channel in drosophila photoreceptors. Neuron 8: 643-651.
62. Hechler B, Lenain N, Marchese P, Vial C, Heim W, Freund M, et al. (2003). A role of the fast ATP-gated P2X, cation channel in thrombosis of small arteries in vivo. J Exp Med 198: 661-667.
63. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu ZY, et al. (2007). Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8: R76.
64. Hoenderop JG, Nilius B, Bindels RJ, (2005). Calcium absorption across epithelia. Physiol Rev 85: 373-422.
65. Honore P, Donnelly-Roberts D, Namovic MT, Hsieh G, Zhu CZ, Mikusa JP, et al. (2006). A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino)methyl]amino}-2,2- dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X(7) receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J Pharmacol Exp Ther 319: 1376-1385.
66. 2+ influx in breast cancer cells. Biochem Biophys Res Commun 411: 786-791.
67. Huang LP, Keyser BM, Tagmose TM, Hansen JB, Taylor JT, Zhuang H, et al. (2004). NNC 55-0396 [(1S, 2S)-2-(2-(N-[(3-benzimidazol-2-yl) propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels. J Pharmacol Exp Ther 309: 193-199.
68. Ip SW, Lan SH, Lu HF, Huang AC, Yang JS, Lin JP, et al. (2012). Capsaicin mediates apoptosis in human nasopharyngeal carcinoma NPC-TW 039 cells through mitochondrial depolarization and endoplasmic reticulum stress. Hum Exp Toxicol 31: 539-549.
69. Jelassi B, Chantome A, Alcaraz-Perez F, Baroja-Mazo A, Cayuela ML, Pelegrin P, et al. (2011). P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness. Oncogene 30: 2108-2122.
70. Jelassi B, Anchelin M, Chamouton J, Cayuela ML, Clarysse L, Li J, et al. (2013). Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors. Carcinogenesis 34: 1487-1496.
71. Jung C, Fandos C, Lorenzo IM, Plata C, Fernandes J, Gene GG, et al. (2009). The progesterone receptor regulates the expression of TRPV4 channel. Pflugers Arch 459: 105-113.
72. Kim BJ, Kim SY, Lee S, Jeon JH, Matsui H, Kwon YK, et al. (2012). The role of transient receptor potential channel blockers in human gastric cancer cell viability. Can J Physiol Pharmacol 90: 175-186.
73. Kim BJ, Nam JH, Kwon YK, So I, Kim SJ, (2013a). The role of waixenicin a as transient receptor potential melastatin 7 blocker. Basic Clin Pharmacol Toxicol 112: 83-89.
74. Kim SY, Yang D, Myeong J, Ha K, Kim SH, Park EJ, et al. (2013b). Regulation of calcium influx and signaling pathway in cancer cells via TRPV6-Numb1 interaction. Cell Calcium 53: 102-111.
75. Kirichok Y, Krapivinsky G, Clapham DE, (2004). The mitochondrial calcium uniporter is a highly selective ion channel. Nature 427: 360-364.
76. Kiyonaka S, Kato K, Nishida M, Mio K, Numaga T, Sawaguchi Y, et al. (2009). Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound. Proc Natl Acad Sci U S A 106: 5400-5405.
77. Knowlton WM, Daniels RL, Palkar R, McCoy DD, McKemy DD, (2011). Pharmacological blockade of TRPM8 ion channels alters cold and cold pain responses in mice. PLoS ONE 6: e25894.
78. Lashinger ESR, Steiginga MS, Hieble JP, Leon LA, Gardner SD, Nagilla R, et al. (2008). AMTB, a TRPM8 channel blocker: evidence in rats for activity in overactive bladder and painful bladder syndrome. Am J Physiol Renal Physiol 295: F803-F810.
79. Lee JM, Davis FM, Roberts-Thomson SJ, Monteith GR, (2011). Ion channels and transporters in cancer. 4. Remodeling of Ca(2+) signaling in tumorigenesis: role of Ca(2+) transport. Am J Physiol Cell Physiol 301: C969-C976.
80. Lee WJ, Monteith GR, Roberts-Thomson SJ, (2006). Calcium transport and signaling in the mammary gland: targets for breast cancer. Biochim Biophys Acta 1765: 235-255.
81. 2+/NFAT-dependent pathways. Oncogene 26: 7380-7385.
82. Lehen'kyi V, Raphael M, Prevarskaya N, (2012). The role of the TRPV6 channel in cancer. J Physiol 590 (Pt 6): 1369-1376.
83. Lester RD, Jo M, Montel V, Takimoto S, Gonias SL, (2007). uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. J Cell Biol 178: 425-436.
84. Leuner K, Kazanski V, Muller M, Essin K, Henke B, Gollasch M, et al. (2007). Hyperforin-A key constituent of St. John's wort specifically activates TRPC6 channels. FASEB J 21: 4101-4111.
85. Lewis RS, (2011). Store-operated calcium channels: new perspectives on mechanism and function. Cold Spring Harb Perspect Biol 3: 1-24.
86. Leybaert L, Sanderson MJ, (2012). Mechanisms and function of intercellular calcium signaling. Physiol Rev 92: 1359-1392.
87. Lo HW, Hsu SC, Xia WY, Cao XY, Shih JY, Wei YK, et al. (2007). Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 67: 9066-9076.
88. Ma S, Gisselmann G, Vogt-Eisele AK, Doerner JF, Hatt H, (2008). Menthol derivative Ws-12 selectively activates transient receptor potential melastatin-8 (Trpm8) ion channels. Pak J Pharm Sci 21: 370-378.
89. Ma X, Cai YF, He DX, Zou C, Zhang P, Lo CY, et al. (2012). Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells. Proc Natl Acad Sci U S A 109: 16282-16287.
90. McAndrew D, Grice DM, Peters AA, Davis FM, Stewart T, Rice M, et al. (2011). ORAI1-mediated calcium influx in lactation and in breast cancer. Mol Cancer Ther 10: 448-460.
91. McNaughton NC, Warre R, Cooper DG, Nasir S, Ranson JL, Randall A, (2000). Potent inhibition of a recombinant low voltage-Activated Ca(2+) channel by SB-209712. Eur J Pharmacol 407: 53-60.
92. Malmberg AB, Yaksh TL, (1995). Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats. Pain 60: 83-90.
93. Maroto R, Raso A, Wood TG, Kurosky A, Martinac B, Hamill OP, (2005). TRPC1 forms the stretch-Activated cation channel in vertebrate cells. Nat Cell Biol 7: 179-U199.
94. 2+ release. J Biochem (Tokyo) 122: 498-505.
95. Middelbeek J, Kuipers AJ, Henneman L, Visser D, Eidhof I, van Horssen R, et al. (2012). TRPM7 is required for breast tumor cell metastasis. Cancer Res 72: 4250-4261.
96. Mignen O, Thompson JL, Shuttleworth TJ, (2008). Orai1 subunit stoichiometry of the mammalian CRAC channel pore. J Physiol 586: 419-425.
97. 2+ signaling. Cell Calcium 40: 261-275.
98. 2+ channels by Ro-40-5967. Circ Res 75: 144-148.
99. 2+ transport. Nat Rev Cancer 7: 519-530.
100. Monteith GR, Davis FM, Roberts-Thomson SJ, (2012). Calcium channels and pumps in cancer: changes and consequences. J Biol Chem 287: 31666-31673.
101. Moran MM, McAlexander MA, Biro T, Szallasi A, (2011). Transient receptor potential channels as therapeutic targets. Nat Rev Drug Discov 10: 601-620.
102. Motiani RK, Abdullaev IF, Trebak M, (2010). A novel native store-operated calcium channel encoded by Orai3: selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptor-negative breast cancer cells. J Biol Chem 285: 19173-19183.
103. 2+ channel that promotes tumorigenesis. FASEB J 27: 63-75.
104. Nelson DW, Gregg RJ, Kort ME, Perez-Medrano A, Voight EA, Wang Y, et al. (2006). Structure-Activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X(7) antagonists. J Med Chem 49: 3659-3666.
105. Neville MC, (2005). Calcium secretion into milk. J Mammary Gland Biol Neoplasia 10: 119-128.
106. Nilius B, (2007). TRP channels in disease. Biochim Biophys Acta 1772: 805-812.
107. Numata T, Shimizu T, Okada Y, (2007). Direct mechano-stress sensitivity of TRPM7 channel. Cell Physiol Biochem 19: 1-8.
108. Okamoto Y, Ohkubo T, Ikebe T, Yamazaki J, (2012). Blockade of TRPM8 activity reduces the invasion potential of oral squamous carcinoma cell lines. Int J Oncol 40: 1431-1440.
109. Ouadid-Ahidouch H, Dhennin-Duthille I, Gautier M, Sevestre H, Ahidouch A, (2013). TRP channels: diagnostic markers and therapeutic targets for breast cancer? Trends Mol Med 19: 117-124.
110. Overes IM, Levenga TH, Vos JCM, van Horssen-Zoetbrood A, van der Voort R, De Mulder PH, et al. (2009). Aberrant expression of the hematopoietic- restricted minor histocompatibility antigen LRH-1 on solid tumors results in efficient cytotoxic T cell-mediated lysis. Cancer Immunol Immunother 58: 429-439.
111. Palmieri C, Rudraraju B, Monteverde M, Lattanzio L, Gojis O, Brizio R, et al. (2012). Methylation of the calcium channel regulatory subunit α2δ-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas. Br J Cancer 107: 375-381.
112. 2+ exchange. Proc Natl Acad Sci U S A 107: 436-441.
113. Pankratov Y, Castro E, Miras-Portugal MT, Krishtal O, (1998). A purinergic component of the excitatory postsynaptic current mediated by P2X receptors in the CA1 neurons of the rat hippocampus. Eur J Neurosci 10: 3898-3902.
114. Panner A, Wurster RD, (2006). T-type calcium channels and tumor proliferation. Cell Calcium 40: 253-259.
115. Paravicini TM, Chubanov V, Gudermann T, (2012). TRPM7: a unique channel involved in magnesium homeostasis. Int J Biochem Cell Biol 44: 1381-1384.
116. Parekh AB, Putney JW, (2005). Store-operated calcium channels. Physiol Rev 85: 757-810.
117. Park WC, Jordan VC, (2002). Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention. Trends Mol Med 8: 82-88.
118. Parks DJ, Parsons WH, Colburn RW, Meegalla SK, Ballentine SK, Illig CR, et al. (2011). Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists. J Med Chem 54: 233-247.
119. Peier AM, Moqrich A, Hergarden AC, Reeve AJ, Andersson DA, Story GM, et al. (2002). A TRP channel that senses cold stimuli and menthol. Cell 108: 705-715.
120. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. (2000). Molecular portraits of human breast tumours. Nature 406: 747-752.
121. Peters AA, Simpson PT, Bassett JJ, Lee JM, Da SL, Reid LE, et al. (2012). Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor-negative breast cancer. Mol Cancer Ther 11: 2158-2168.
122. Pla AF, Ong HL, Cheng KT, Brossa A, Bussolati B, Lockwich T, et al. (2012). TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-Activated actin remodeling. Oncogene 31: 200-212.
123. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, et al. (2010). Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12: R68.
124. Prevarskaya N, Zhang L, Barritt G, (2007). TRP channels in cancer. Biochim Biophys Acta 1772: 937-946.
125. Prevarskaya N, Skryma R, Shuba Y, (2011). Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer 11: 609-618.
126. Putney JW, (1986). A model for receptor-regulated calcium entry. Cell Calcium 7: 1-12.
127. Putney JW, (2011). The physiological function of store-operated calcium entry. Neurochem Res 36: 1157-1165.
128. Rami HK, Thompson M, Stemp G, Fell S, Jerman JC, Stevens AJ, et al. (2006). Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development. Bioorg Med Chem Lett 16: 3287-3291.
129. Ramsey IS, Delling M, Clapham DE, (2006). An introduction to TRP channels. Annu Rev Physiol 68: 619-647.
130. Reinhardt TA, Filoteo AG, Penniston JT, Horst RL, (2000). Ca(2+)-ATPase protein expression in mammary tissue. Am J Physiol Cell Physiol 279: C1595-C1602.
131. 2+-ATPase isoform 2 impairs calcium transport into milk. J Biol Chem 279: 42369-42373.
132. Rios E, Brum G, (1987). Involvement of dihydropyridine receptors in excitation-contraction coupling in skeletal muscle. Nature 325: 717-720.
133. Robert V, Triffaux E, Savignac M, Pelletier L, (2011). Calcium signalling in T-lymphocytes. Biochimie 93: 2087-2094.
134. Roberts-Thomson SJ, Peters AA, Grice DM, Monteith GR, (2010). ORAI-mediated calcium entry: mechanism and roles, diseases and pharmacology. Pharmacol Ther 127: 121-130.
135. 2+ for cancer cell proliferation and survival. Nat Rev Cancer 8: 361-375.
136. Runnels LW, Yue L, Clapham DE, (2001). TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 291: 1043-1047.
137. Sanchez AM, Sanchez MG, Malagarie-Cazenave S, Olea N, Diaz-Laviada I, (2006). Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin. Apoptosis 11: 89-99.
138. Schneider BP, Winer EP, Foulkes WD, Garber J, Perou CM, Richardson A, et al. (2008). Triple-negative breast cancer: risk factors to potential targets. Clin Cancer Res 14: 8010-8018.
139. Shulman LN, Willett W, Sievers A, Knaul FM, (2010). Breast cancer in developing countries: opportunities for improved survival. J Oncol 2010: 595167.
140. Smith PL, Maloney KN, Pothen RG, Clardy J, Clapham DE, (2006). Bisandrographolide from Andrographis paniculata activates TRPV4 channels. J Biol Chem 281: 29897-29904.
141. Sorlie T, (2009). Introducing molecular subtyping of breast cancer into the clinic? J Clin Oncol 27: 1153-1154.
142. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98: 10869-10874.
143. Storr SJ, Carragher NO, Frame MC, Parr T, Martin SG, (2011). The calpain system and cancer. Nat Rev Cancer 11: 364-374.
144. Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR, et al. (2003). ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112: 819-829.
145. Surprenant A, North RA, (2009). Signaling at purinergic P2X receptors. Annu Rev Physiol 71: 333-359.
146. Taylor JM, Simpson RU, (1992). Inhibition of cancer cell-growth by calcium-channel antagonists in the athymic mouse. Cancer Res 52: 2413-2418.
147. 2+ channels suppresses human breast cancer cell proliferation. Cancer Lett 267: 116-124.
148. Thorneloe KS, Sulpizio AC, Lin ZJ, Figueroa DJ, Clouse AK, McCafferty GP, et al. (2008). N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3- hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2- carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: part I. J Pharmacol Exp Ther 326: 432-442.
149. Thorneloe KS, Cheung M, Bao WK, Alsaid H, Lenhard S, Jian MY, et al. (2012). An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure. Sci Transl Med 4: 159ra148.
150. Tsavaler L, Shapero MH, Morkowski S, Laus R, (2001). Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Res 61: 3760-3769.
151. Tsien RW, Lipscombe D, Madison DV, Bley KR, Fox AP, (1988). Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci 11: 431-438.
152. Valero ML, de Queiroz FM, Stuhmer W, Viana F, Pardo LA, (2012). TRPM8 ion channels differentially modulate proliferation and cell cycle distribution of normal and cancer prostate cells. PLoS ONE 7: e51825.
153. VanHouten J, Sullivan C, Bazinet C, Ryoo T, Camp R, Rimm DL, et al. (2010). PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancer. Proc Natl Acad Sci U S A 107: 11405-11410.
154. Vargo-Gogola T, Rosen JM, (2007). Modelling breast cancer: one size does not fit all. Nat Rev Cancer 7: 659-672.
155. Varnai P, Hunyady L, Balla T, (2009). STIM and Orai: the long-Awaited constituents of store-operated calcium entry. Trends Pharmacol Sci 30: 118-128.
156. Watanabe H, Davis JB, Smart D, Jerman JC, Smith GD, Hayes P, et al. (2002). Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives. J Biol Chem 277: 13569-13577.
157. Watkins JC, Jane DE, (2006). The glutamate story. Br J Pharmacol 147 (Suppl 1): S100-S108.
158. Wes PD, Chevesich J, Jeromin A, Rosenberg C, Stetten G, Montell C, (1995). TRPC1, a human homolog of a Drosophila store-operated channel. Proc Natl Acad Sci U S A 92: 9652-9656.
159. Yang SL, Cao Q, Zhou KC, Feng YJ, Wang YZ, (2009a). Transient receptor potential channel C3 contributes to the progression of human ovarian cancer. Oncogene 28: 1320-1328.
160. Yang SY, Zhang JJL, Huang XY, (2009b). Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 15: 124-134.
161. Zhang L, Barritt GJ, (2004). Evidence that TRPM8 is an androgen-dependent Ca2+ channel required for the survival of prostate cancer cells. Cancer Res 64: 8365-8373.
162. 2+ channel activity. Proc Natl Acad Sci U S A 103: 9357-9362.
163. Zhang W, Couldwell WT, Song H, Takano T, Lin JHC, Nedergaard M, (2000). Tamoxifen-induced enhancement of calcium signaling in glioma and MCF-7 breast cancer cells. Cancer Res 60: 5395-5400.
164. Zhuang LY, Peng JB, Tou LQ, Takanaga H, Adam RM, Hediger MA, et al. (2002). Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies. Lab Invest 82: 1755-1764.
165. Zierler S, Yao GM, Zhang Z, Kuo WC, Porzgen P, Penner R, et al. (2011). Waixenicin a inhibits cell proliferation through magnesium-dependent block of transient receptor potential melastatin 7 (TRPM7) channels. J Biol Chem 286: 39328-39335.